PCSK9 and atherosclerosis: The current study aimed to examine the effects of Dennd5b−/− on plasma lipoproteins, atherosclerosis, and hepatic lipid metabolism under conditions of induced hypercholesterolemia in mice fed a Western diet and infected with an AAV-inducing hepatic overexpression of the PCSK9 gain-of-function variant D377Y.